Skip to content

OCRA Corporate Sponsors & Partners

Corporate Sponsors

We are deeply grateful to our past and current corporate partners for supporting our mission to find a cure and improve the lives of those affected by ovarian and other gynecologic cancers.

Partner with us

Corporate Partners

Conflict of Interest Statement — Industry Partners

  • Corporate partners including industry do not shape OCRA’s agenda, research, or advocacy.
  • In 2023, industry partners represented 8% of OCRA’s overall revenue.
  • If an industry partner sponsors an OCRA program, grant, or educational materials, it is publicly acknowledged and the supporting company has no editorial or strategic input.
  • Any reference to a specific commercial product or service does not constitute or imply an endorsement by OCRA of the product or service or its producer or provider. The views and opinions expressed in any referenced document or on any referenced website do not necessarily reflect those of OCRA.
Read our conflict of interest policy

Related Topics

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

Action Alert: Urge Congress to Pass Final Bill on Cancer Research Funding and Early Detection

The Congressional Appropriations Committees have released a combined FY2026  Defense/Labor, Health and Human Services bill—and it includes several critical investments and policy provisions that would significantly strengthen the federal response to ovarian and other gynecologic cancers. This bill represents meaningful progress for our community, but it is not final. Congress must act swiftly to advance and … Continued

Read more

OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection

OCRA Urges Immediate Passage of Bill Supporting Ovarian Cancer Research, Education, and Early Detection

The Ovarian Cancer Research Alliance today praised the release of the FY2026 Labor, Health and Human Services, Education, and Related Agencies appropriations bill by the Congressional Appropriations Committees and urged swift action to advance and enact the legislation. The bill includes critical funding and policy provisions supporting ovarian cancer research, education, and early detection. Add Your Voice … Continued

Read more

Ovarian Cancer Research Alliance Reports Year of Significant Progress Across Research, Advocacy, and Patient Support

Ovarian Cancer Research Alliance Reports Year of Significant Progress Across Research, Advocacy, and Patient Support

Organization launches global initiatives, expands patient programs, strengthens policy leadership, and achieves record engagement in 2025 OCRA is grateful for our community’s generous support, which helped raise over $2.4 million, surpassing our year-end campaign goal and closing out a year of progress.  NEW YORK, NY — [January 13, 2026] — In 2025, Ovarian Cancer Research Alliance (OCRA) delivered … Continued

Read more

Stay Informed

Get email updates about research news, action alerts, and ways to join the fight.

We care about your data. Read our privacy policy.